CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-16 | Mahoney Michael F Director | Grant or award | +2,184 | $57.52 | $126K | 4,001 |
| 2024-05-16 | KIRBY J SCOTT Director | Grant or award | +2,912 | $57.52 | $167K | 5,633 |
| 2024-05-16 | Finucane Anne A. Director | Grant or award · Share Credits | +2,184.02 | $57.52 | $126K | 9,747.66 |
| 2024-05-16 | FARAH ROGER N Director | Grant or award · Share Credits | +5,302.5 | $57.52 | $305K | 35,561.33 |
| 2024-05-16 | DEPARLE NANCY ANN Director | Grant or award | +2,314 | $57.52 | $133K | 31,838 |
| 2024-05-16 | DECOUDREAUX ALECIA A Director | Grant or award · Share Credits | +2,184.02 | $57.52 | $126K | 31,994.3 |
| 2024-05-16 | BROWN C DAVID II Director | Grant or award | +2,314 | $57.52 | $133K | 121,434 |
| 2024-05-16 | Balser Jeffrey R. Director | Grant or award | +2,184 | $57.52 | $126K | 7,277 |
| 2024-05-16 | AGUIRRE FERNANDO Director | Grant or award | +2,347 | $57.52 | $135K | 34,523 |
| 2024-05-02 | LUDWIG EDWARD J Director | Purchase | +1,000 | $53.88 | $54K | 21,630 |
| 2024-05-02 | Mahoney Michael F Director | Purchase | +9,181 | $54.49 | $500K | 9,356 |
| 2024-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −1,892 | $79.56 | $151K | 9,592 |
| 2024-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −1,112 | $79.56 | $88K | 8,480 |
| 2024-04-01 | Clark James David SVP, Cont & Chief Acct Officer | Grant or award | +10,683 | $79.56 | $850K | 15,109 |
| 2024-04-01 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Shares withheld for taxes | −1,473 | $79.56 | $117K | 12,036.98 |
| 2024-04-01 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Shares withheld for taxes | −825 | $79.56 | $66K | 11,211.98 |
| 2024-04-01 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Grant or award | +6,913 | $79.56 | $550K | 23,666 |
| 2024-04-01 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Grant or award · Stock Option | +28,735 | $79.56 | $2.3M | 28,735 |
| 2024-04-01 | Havanec Laurie P. EVP and Chief People Officer | Shares withheld for taxes | −7,630 | $79.56 | $607K | 37,553 |
| 2024-04-01 | Havanec Laurie P. EVP and Chief People Officer | Grant or award | +9,426 | $79.56 | $750K | 9,426 |
Page 9 of 15 · 283 trades